Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ovarian cancer
Pharma
GSK trial result mirrors Merck's problem in ovarian cancer
Merck's and GSK's similar overall survival setbacks suggest that PD-1 inhibitors may not be for ovarian cancer after all.
Angus Liu
Dec 20, 2024 10:46am
Keytruda-Lynparza combo scores tepid win in ovarian cancer trial
Dec 9, 2024 11:18am
In 3rd bankruptcy bid, J&J sweetens talc settlement offer to $8B
Sep 23, 2024 9:33am
Oregon judge sides with J&J, overturning $260M talc verdict
Sep 17, 2024 8:17am
ESMO: GSK's Zejula, pharma&'s Rubraca-Opdivo combo disappoint
Sep 14, 2024 8:45am
Verastem sets first awareness day for rare ovarian cancer
Sep 3, 2024 3:20pm